Nucleus RadioPharma
Davidson, North Carolina, United States · Biotechnology, Health Care, Manufacturing · 40 employees
Nucleus RadioPharma is an innovative CDMO dedicated to the development and manufacturing of targeted radiotherapies. With an emphasis on innovation and quality, Nucleus provides an array of services, from formulation and analytical development to regulatory documentation and drug product manufacturing. Its technology platforms are at the forefront of radiopharmaceutical research, designed to advan
Funding history
- Funding Round — $66.1M — Apr 2024
- Funding Round — $6.0M — Apr 2024
Recent signals
- Aug 20, 2025: Nucleus RadioPharma Appoints Dr. Stephen Hahn as Chief Executive Officer
- Jun 05, 2024: Raised funding
- Jun 05, 2024: Nucleus RadioPharma Appoints Tyrell Rivers as Executive Director of Corporate Ventures
- Apr 11, 2024: Raised $66.1M
- Apr 11, 2024: Raised $6.0M
- Mar 27, 2024: Nucleus RadioPharma Appoints Chris McDonald as Global Head of Technical Operations
- Dec 14, 2023: Nucleus RadioPharma Appoints Former McKesson, Novo Nordisk Executive Kathy Spencer-Pike as Chief Commercial Officer to Drive Business Growth
- Dec 07, 2023: Nucleus RadioPharma Appoints Industry Veteran Mark Przekop as Chief Operating Officer to Lead Supply Chain Strategy
See plans & pricing → Track Nucleus RadioPharma’s funding, hiring, and signals — with verified contacts — on Fundz.